CLDF Title
Home | Contact Us | Bookmark
HBV HE HCC HCV
About CLDF Centers of Educational Expertise  
Live CME Meetings Telewebs Webcasts Slide Library Abstract Library Conference Highlights
 
Back  
 
Reuters Health Information (2004-08-23): Portosystemic shunts can safely treat portal hypertension in children

Clinical

Portosystemic shunts can safely treat portal hypertension in children

Last Updated: 2004-08-23 14:58:06 -0400 (Reuters Health)

NEW YORK (Reuters Health) - Findings from a new study suggest that portosystemic shunts (PSS), especially the distal splenorenal shunt, are a safe and effective therapy for portal hypertension in children.

The results are based on a study of 20 children who underwent shunting at the University of Nebraska Medical Center in Omaha between 1987 and 2002, according to the report in the Journal of the American College of Surgeons for August.

In all cases, the indication for PSS was variceal bleeding despite endoscopic therapy. The causes of portal hypertension included portal vein thrombosis in 13 children, biliary atresia in 3, congenital hepatic fibrosis in 2, hepatitis C cirrhosis in 1 and Budd-Chiari syndrome in 1 patient. With the exception of two patients who were Child-Turcotte-Pugh class B, all of the subjects were class A at the time of shunting.

Seventeen children received a distal splenorenal shunt and three received a mesocaval venous interposition shunt, lead author Dr. Jean F. Botha and colleagues note. None of the patients died within 30 days of surgery.

At a median follow-up period of 31 months, 19 patients were alive with no evidence of further gastrointestinal bleeding. One patient underwent liver transplantation 2 years after shunting and one patient died of liver failure while on the transplantation waiting list.

In terms of long-term sequelae, two patients experienced worsening ascites, one patient experienced two episodes of hematemesis, one patient had mild encephalopathy, and one patient required angioplasty for shunt stenosis.

The findings suggest that PSS is a useful therapy for many children with portal hypertension, the authors state. "Liver transplantation should be reserved for children with poor synthetic function associated with variceal bleeding," they add.

J Am Coll Surg 2004;199:179-185.

 
 
 
 
                 
 
HBV
Webcasts
Slide Library
Abstract Library
 
HE
Live CME Meetings
Webcasts
Slide Library
Abstract Library
 
HCC
Slide Library
Abstract Library
 
 
HCV
Live CME Meetings
Webcasts
Slide Library
Abstract Library
 
CLDF Follow Us
   
 
About CLDF
Mission Statement
Board of Trustees
Board of Advisors
CLDF Supporters
 
Other Resources
Liver News Library
Journal Abstracts
Hep C Link to Care
 
Centers of
Educational Expertise
Regional Map
     
   
  The Chronic Liver Disease Foundation is a non-profit organization with content developed specifically for healthcare professionals.
© Copyright 2012-2014 Chronic Liver Disease Foundation. All rights reserved. This site is maintained as an educational resource for US healthcare providers only.
Use of this Web site is governed by the Chronic Liver Disease Foundation terms of use and privacy statement.